STK-026

N/A

Report date: 2023/07/11 16:07:55

Base Information

Drug NameSTK-026
Drug Alias NameSTK-026
ClassificationBiologics
Mechanisms of ActionInterleukin-12 subunit beta stimulants
TargetsInterleukin-12 subunit beta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynthekine Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynthekine Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A